亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會(huì)員登錄|免費(fèi)注冊(cè)|忘記密碼|管理入口 返回主站||保存桌面|手機(jī)瀏覽|聯(lián)系方式|購(gòu)物車
企業(yè)會(huì)員第1年

無(wú)錫同創(chuàng)生物科技有限公司  

辣根過(guò)氧化物酶,5-溴-4氯-3吲哚-神經(jīng)氨酸,吡咯酯等

搜索
新聞中心
  • 暫無(wú)新聞
產(chǎn)品分類
  • 暫無(wú)分類
聯(lián)系方式
  • 聯(lián)系人:張倩
  • 電話:13655185676
  • 郵件:wuxitongchuang@yahoo.cn
  • 傳真:0510-85899582
  • QQ:1760363918
站內(nèi)搜索
 
榮譽(yù)資質(zhì)
  • 暫未上傳
友情鏈接
  • 暫無(wú)鏈接
TTC
單價(jià) 面議對(duì)比
詢價(jià) 暫無(wú)
發(fā)貨 江蘇無(wú)錫市付款后3天內(nèi)
品牌 MRC
Cas 298-96-4
過(guò)期 長(zhǎng)期有效
更新 2024-01-10 11:52
 
詳細(xì)信息

中文名氯化三苯基四氮唑
英文名】2,3,5-Triphenyltetrazolium chloride
分子式】C19H15ClN4
分子量334.81
CAS298-96-4
含量:≥99.0%
外觀白色至淺黃色結(jié)晶粉末
用途】還原糖的靈敏試劑,區(qū)分乙醇、酮類和簡(jiǎn)單醛,測(cè)定脫氫酶的活性,滴定***,***和***等,農(nóng)藥殘留量分析。
©2025 無(wú)錫同創(chuàng)生物科技有限公司 版權(quán)所有   技術(shù)支持:化工網(wǎng)   訪問(wèn)量:36429  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |